ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
Temporal onset of non-motor symptoms and the body-first/brain-first dichotomy in Parkinson's disease: a cross-sectional single center experience.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pesticide exposure and multidomain symptom burden in Parkinson's disease: a longitudinal triangulation study.NPJ Parkinson's disease · 2026Article
- Brain-First vs. Body-First Models in Neurodegenerative Disease: A Perspective Review.NeuroSci · 2026Review
- Development and emerging trends in gastrointestinal dysfunction of Parkinson's disease: a decade-long bibliometric analysis.Frontiers in aging neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Parkinson's disease (PD) is characterized by an array of motor symptoms and non-motor symptoms (NMS), with growing interest in the chronology of NMS. The α -Synuclein Origin site and Connectome (SOC) model proposes body-first and brain-first subtypes, based on the origin and spread of α -synuclein pathology, with distinct clinical phenotypes. To evaluate the temporal profile of onset of the NMS in relation to the motor symptoms in patients with PD. Additionally, motor and non-motor differences based on the SOC model subtyping were evaluated. Interim data of 400 patients with PD was analysed from a prospective study. Motor symptoms and NMS were assessed using the MDS-UPDRS and MDS-NMS. Patients were classified based on their onset of NMS as pre-motor, concurrent with motor onset, or post-motor. Patients were also subtyped as body-first (RBD: pre-motor + at-motor onset) or brain-first (RBD: post-motor onset/no RBD). All patients had at least one NMS. Pain (63%), sleep disturbances (61.75%), and anxiety (55.3%) were most prevalent. About 26.5% experienced pre-motor NMS; however, pre-motor hyposmia and constipation had a lower prevalence than expected. Body-first patients (9.5%) had significantly more cognitive decline, autonomic symptoms, while brain-first patients had higher motor severity, LEDD, pain, and PIGD phenotype. Temporal mapping of NMS revealed distinct patterns of symptom chronology and pathogenesis of these symptoms. The observed dichotomy in the brain-first and body-first subtypes partially supports the conceptual framework of the SOC dual-pathway model. Further exploration, particularly longitudinal evolution may offer further insights into the pathogenesis of NMS in PD.
Indexed as
Identifiers
40796681What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.